These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 668274)

  • 21. [Paget's degeneration of the juxta-alveolar portion of the mandible in subjects with generalized osteoporosis. Clinical study].
    Tanzi VG; Chicco G; Pallassini A; Improta M; Asti O
    Arch Stomatol (Napoli); 1989 Oct; 30(4):685-97. PubMed ID: 2641653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thyrocalcitonin therapy and its effect on serum and urinary indices in Paget's disease].
    Balaba TIa; Zatsepin ST; Kuz'mina LP; Zamiatkina OG
    Ortop Travmatol Protez; 1979 May; (5):46-51. PubMed ID: 377180
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of Paget's disease with calcitonin.
    DeRose J; Avramides A; Baker RK; Wallach S
    Semin Drug Treat; 1972; 2(1):51-5. PubMed ID: 5065517
    [No Abstract]   [Full Text] [Related]  

  • 24. [Paget's disease. Acute attacks treated with calcitonin. Thermographic study].
    Camus JP; Tricoire J; Mariel L; Prier A
    Nouv Presse Med; 1973 Oct; 2(38):2517-9. PubMed ID: 4763456
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical and metabolic studies of Paget's bone disease treated with thyrocalcitonin (author's transl)].
    Kocián J
    Cas Lek Cesk; 1981 May; 120(19):571-5. PubMed ID: 7237502
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of Paget's disease of bone with diphosphonates and calcitonin].
    Ziegler R; Holz G; Minne H; Delling G
    Verh Dtsch Ges Inn Med; 1978; (84):1122-5. PubMed ID: 741902
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic sequences calcitonin-EHDP and EHDP-calcitonin in Paget's disease. Histological and biological study].
    Eisinger J; Laponche AM; Ouaniche J
    Rev Rhum Mal Osteoartic; 1986 Mar; 53(3):183-5. PubMed ID: 3085204
    [No Abstract]   [Full Text] [Related]  

  • 28. [Paget's disease and calcitonin. Personal experience].
    Louyot P; Pourel J
    Acta Orthop Belg; 1974; 40(4):538-45. PubMed ID: 4469725
    [No Abstract]   [Full Text] [Related]  

  • 29. [Metabolic effects of calcitonin in man].
    Caniggia A; Gennari C
    Minerva Med; 1973; 64(43):2249-58. PubMed ID: 4727514
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of a long-term treatment with the aminosuberic analog of eel calcitonin on osteocalcin in Paget's disease.
    Caniggia A; Nuti R; Galli M; Turchetti V; Righi G
    Panminerva Med; 1987; 29(1):1-5. PubMed ID: 3496574
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic application of calcitonin].
    Fujita T
    Nihon Rinsho; 1971 Jul; 29(7):1789-95. PubMed ID: 4948491
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
    Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chronopharmacological effect of porcine calcitonin in Paget's disease of the bone].
    Tarquini B; Ciapini A; Benvenuti M; Moretti R; Cherici R; Comparini T; Neri B
    Clin Ter; 1980 Sep; 94(6):659-70. PubMed ID: 7460500
    [No Abstract]   [Full Text] [Related]  

  • 34. Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.
    Haddad JG; Caldwell JG
    J Clin Invest; 1972 Dec; 51(12):3133-41. PubMed ID: 4674398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differential characteristics of Paget's disease of bone with or without osteoporosis circumscripta of the skeleton (author's transl)].
    Macera C
    Rev Med Chil; 1978 Nov; 106(11):869-73. PubMed ID: 749108
    [No Abstract]   [Full Text] [Related]  

  • 36. [Influence of porcine calcitonin in 3 healthy patients and in a female patient with Paget's disease].
    Aznar Reig A; Zamora Madaria E; Herrera Justiniano E; Rubio Rubio JM; Gómez San Millán M; Merchante C
    Rev Iber Endocrinol; 1971; 18(107):419-42. PubMed ID: 5133441
    [No Abstract]   [Full Text] [Related]  

  • 37. [Calcitonin as a therapeutic drug].
    Ziegler R
    Ther Umsch; 1985 Jun; 42(6):358-65. PubMed ID: 2410993
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of Paget's disease of bone using synthetic salmon calcitonin administered intranasally].
    Reginster JY; Albert A; Franchimont P
    Rev Med Liege; 1986 Jan; 41(1):13-8. PubMed ID: 3952394
    [No Abstract]   [Full Text] [Related]  

  • 39. Calcitonin therapy for bone disease and hypercalcemia.
    Avioli LV
    Arch Intern Med; 1982 Nov; 142(12):2076-9. PubMed ID: 7138154
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapy of Paget's disease].
    Silveri F
    Clin Ter; 1987 Oct; 123(2):85-94. PubMed ID: 2972476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.